Manufacturing
Rely on Our expertise
Our complete suite of services and solutions for mRNA, monoclonal antibodies and recombinant proteins.
Drug Substance
Our Hopkinton, MA facility is ISO 13485:2016 certified and provides biomanufacturing services for GMP and BPG production of mRNA, protein therapeutics and vaccines, and therapeutic antibodies.
- Established quality system supports production of early-phase bulk drug and diagnostic products
- End-to-end solutions cover mRNA, protein and antibody large scale production, in-process testing and batch release, lipid nanoparticle (LNP) fill-finish — all manufactured in ISO 7 suites with GMP-compliant single-use equipment
Drug Product
Our Glasgow, UK and Camarillo, CA sites offer expertise and capabilities for sterile drug product manufacturing from early clinical through large-scale supply.
- Providing a complete suite of services for all sterile dosage forms — liquid, suspension or lyophilized
- Covering a broad range of therapeutics in mRNA, proteins, mAbs, peptides, oligonucleotides to deliver large-scale fill-finish needs
Discovery
Make the most of your molecule
With services ranging from antibody-based drug discovery to viral vector, cell engineering and more, Curia goes the extra mile in getting your product idea off to a fast start
Development
Validate and accelerate your compound
As your dedicated ally, Curia gives you an inside track with stable CHO cell line development, upstream/downstream process development, formulation development and antibody developability analysis
Manufacturing
Rely on our expertise
Curia can provide GMP manufacturing services that work with your needs for bulk drug substance, large scale production, and on-site assays and analytics for in-process testing and batch release